UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045247
Receipt number R000051553
Scientific Title Development and Validation of a Measure to Assess Care-related Emotions of Family Members of Individuals with Mental Disorders
Date of disclosure of the study information 2021/09/01
Last modified on 2024/09/03 14:29:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Questionnaire Survey of the Care Burden of Family Members of People with Mental Illnesses

Acronym

A Survey of the Care Burden of Mental Illnesses

Scientific Title

Development and Validation of a Measure to Assess Care-related Emotions of Family Members of Individuals with Mental Disorders

Scientific Title:Acronym

Development and Validation of the CREAM

Region

Japan


Condition

Condition

Schizophrenia (SZ), schizoaffective disorder (SZA), bipolar disorder (BD),
and anorexia nervosa (AN)

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to validate the psychometric properties of CREAM.

Basic objectives2

Others

Basic objectives -Others

The study will also validate its screening performance.

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

We will examine the CREAM's structural validity, reliability (internal consistency and test-retest reliability), and construct and criterion validities.

Key secondary outcomes

We will also examine its criterion validity.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

74 years-old >=

Gender

Male and Female

Key inclusion criteria

The inclusion criteria for the survey are family members who (1) are aged between 18 and 74 years; (2) have relatives diagnosed with SZ, SZA, BD, or AN; (3) are ill individuals' parents, siblings, or spouses; and (4) have relatives being treated through regular visits, being admitted to medical facilities, or having had the last visit to medical facilities within the past year.

Key exclusion criteria

The exclusion criteria are family members who (1) are not ill individuals' parents, siblings, or spouses and (2) have relatives having had the last visit to medical facilities before the past year or not knowing the treatment condition.

Target sample size

700


Research contact person

Name of lead principal investigator

1st name Nao
Middle name
Last name Shiraishi

Organization

Nagoya City University, Graduate School of Medical Sciences

Division name

Department of Psychiatry and Cognitive-Behavioral Medicine

Zip code

467-8601

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan

TEL

+81-52-853-8048

Email

nao-shiraishi@umin.ac.jp


Public contact

Name of contact person

1st name Nao
Middle name
Last name Shiraishi

Organization

Nagoya City University, Graduate School of Medical Sciences

Division name

Department of Psychiatry and Cognitive-Behavioral Medicine

Zip code

467-8601

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan

TEL

+81-52-853-8048

Homepage URL


Email

nao-shiraishi@umin.ac.jp


Sponsor or person

Institute

Nagoya City University

Institute

Department

Personal name



Funding Source

Organization

The Japanese Ministry of Education, Science, and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Institutional Review Board of Nagoya City University Graduate School of Medical Sciences and Nagoya City University Hospital

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan

Tel

+81-52-858-7215

Email

clinical_research@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 01 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000051553

Publication of results

Partially published


Result

URL related to results and publications

https://onlinelibrary.wiley.com/doi/10.1002/pcn5.55

Number of participants that the trial has enrolled

611

Results

Our new measure demonstrated robust structural validity and excellent internal consistency. Moreover, we examined the role of caregiving burden and sense of coherence as mediating factors between the functional disabilities of patients with psychotic disorders and the negative and positive emotions of their siblings, using structural equation modeling (SEM). As the results, an approach that addresses caregiving both burden and sense of coherence could be effective in supporting siblings emotionally.

Results date posted

2024 Year 09 Month 03 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

In the SEM study, the sample included 237 siblings aged 42.3 years (mean) with a male-to-female ratio of 0.88 and 237 patients with schizophrenia (80.2%) or schizoaffective disorder (19.8%).

Participant flow

A nationwide online survey was used to screen and recruit family members, including siblings and spouses, of patients with psychotic disorders.

Adverse events

Not applicable

Outcome measures

Patients' disabilities in their work lives, socializing, and family communication, as well as the family members' care burden, sense of coherence, and positive and negative emotions, were assessed.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 09 Month 11 Day

Date of IRB

2020 Year 01 Month 30 Day

Anticipated trial start date

2021 Year 11 Month 18 Day

Last follow-up date

2021 Year 12 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Registered people are invited to participate in the survey from the nationwide online survey panel that is managed by Rakuten Insight.


Management information

Registered date

2021 Year 08 Month 24 Day

Last modified on

2024 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051553